Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Neoplasms 267Breast Neoplasms 256Lung Neoplasms 130Prostatic Neoplasms 113Colorectal Neoplasms 106Carcinoma, Non-Small-Cell Lung 101Pancreatic Neoplasms 67Carcinoma, Hepatocellular 53Ovarian Neoplasms 50Stomach Neoplasms 49Multiple Myeloma 49Hematologic Neoplasms 48Urinary Bladder Neoplasms 47Brain Neoplasms 45Leukemia, Myeloid, Acute 42Melanoma 41Head and Neck Neoplasms 40Esophageal Neoplasms 40Disease 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Colonic Neoplasms 35Rectal Neoplasms 34Liver Neoplasms 34Lymphoma 32Neoplasm Metastasis 31Leukemia, Lymphocytic, Chronic, B-Cell 30Endometrial Neoplasms 30Uterine Cervical Neoplasms 27Thyroid Neoplasms 27Kidney Neoplasms 27

Interventions

Mass Screening 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Postural Orthostatic Tachycardia Syndrome × 90 days × Clear all
NCT07143669 2026-05-22

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Blueprint Medicines Corporation

Recruiting
450 enrolled
MyeloidOther hematologic neoplasm

Mastocytosis, Leukemia, Myelomonocytic, Chronic, Postural Orthostatic Tachycardia Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡